Understanding the molecular mechanisms underlying AAT resistance is essential to optimize treatment strategies.<h4>Methods</h4>To identify factors involved in AAT resistance, we performed integrated transcriptomic and proteomic analyses on ccRCC cell lines subjected to either transient AAT treatment or with established acquired resistance. This evidence concerns the gene SERPINA1 and nonpapillary renal cell carcinoma.